CAS 84575-10-0: 9H-Pyrano[2,3-f]-1,4-benzodioxin-9-one,2,3- dihydro-3-(4-hydroxy-3,5-dimethoxyphenyl)- 2-(hydroxymethyl)-5-methoxy-,(2R,3R)-rel-

Cleomiscosin C is a natural coumarin compound, which is sourced from plants of the genus Cleome, commonly found in tropical and subtropical regions. It functions primarily through its ability to modulate multiple biological pathways, including anti-inflammatory and antioxidant activities. This modulatory action is attributed to its chemical structure, enabling it to interact with cellular receptors and enzymes involved in oxidative stress response and inflammation. Cleomiscosin C is of significant interest in the scientific community due to its potential therapeutic applications. It is being investigated for its efficacy in treating conditions associated with oxidative stress and inflammation, such as cardiovascular diseases and certain inflammatory disorders. Furthermore, its natural origin and the presence of bioactive constituents make it a subject of study for drug development and nutraceutical applications. Continuous research is vital to fully elucidate its mechanisms and expand its potential therapeutic uses.

Cleomiscosin C, an antioxidant, inhibits apoB-100 oxidation (IC50: 23.6µM Cu2+, 3.9µM HOCl), may prevent LDL oxidation; A, B, and C protect the liver.